Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA

  • Authors:
    • Zhuo Wu
    • Yanyan Zeng
    • Mingkang Zhong
    • Bin Wang
  • View Affiliations

  • Published online on: March 6, 2014     https://doi.org/10.3892/mmr.2014.2023
  • Pages: 1787-1793
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lung cancer is the major cause of cancer‑associated mortality worldwide and the invasive and metastatic characteristics of lung tumor cells are responsible for their high malignancy. Protease‑activated receptor 1 (PAR1) is a G‑protein‑coupled receptor (GPCR) which is activated by a unique proteolytic mechanism. PARs have crucial roles in hemostasis and thrombosis as well as tumor progression. RNA interference (RNAi) is a fundamental cellular mechanism for gene silencing that is able to be harnessed for the development of novel anti‑cancer drugs. In the present study, PAR1 was successfully inhibited by using Lipofectamine RNAiMAX transfection reagent to deliver siRNA. Inhibition occurred at the mRNA and protein level as determined by polymerase chain reaction and western blot analysis. Furthermore, the growth and invasion of tumor cells were significantly decreased. In conclusion, the present study demonstrated that the progression of A549 cells is able to be inhibited by knockdown of PAR1 expression. Efficient delivery of the specific siRNA targeting PAR1 may be used for further study in clinical cancer therapy.
View Figures
View References

Related Articles

Journal Cover

May-2014
Volume 9 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu Z, Zeng Y, Zhong M and Wang B: Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA. Mol Med Rep 9: 1787-1793, 2014.
APA
Wu, Z., Zeng, Y., Zhong, M., & Wang, B. (2014). Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA. Molecular Medicine Reports, 9, 1787-1793. https://doi.org/10.3892/mmr.2014.2023
MLA
Wu, Z., Zeng, Y., Zhong, M., Wang, B."Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA". Molecular Medicine Reports 9.5 (2014): 1787-1793.
Chicago
Wu, Z., Zeng, Y., Zhong, M., Wang, B."Targeting A549 lung adenocarcinoma cell growth and invasion with protease‑activated receptor‑1 siRNA". Molecular Medicine Reports 9, no. 5 (2014): 1787-1793. https://doi.org/10.3892/mmr.2014.2023